Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

CSP Introduces Activ-Blister® Technology for Pharmaceutical Manufacturers

Published: Monday, October 22, 2012
Last Updated: Monday, October 22, 2012
Bookmark and Share
Innovative desiccated blister packaging protects moisture and oxygen-sensitive solid dose pharmaceuticals for better product performance.

CSP Technologies has announced the global launch of its Activ-Blister® desiccated blister packaging for the pharmaceutical industry.

Activ-Blister® desiccant film technology controls the internal atmosphere of each individual blister cavity, protecting moisture and oxygen-sensitive solid dose pharmaceuticals.

The result is optimized product stability, increased shelf-life, and greater consumer convenience.

Activ-Blister® also helps ensure consumer safety, because unlike conventional desiccants, there is no chance of accidental ingestion.

Activ-Blister® offers manufacturers superior flexibility in packaging design, providing an opportunity to differentiate their products.

By eliminating the need for traditional desiccant tablets in separate blister wells, Activ-Blister® allows for a slimmer, more convenient packaging form-factor while simplifying the end-user experience.

In addition, by featuring product protection without increased blister size, Activ-Blister® provides manufacturers with potential cost savings through reduced material usage, freight costs and fuel consumption.

“Activ-Blister® is an entirely new approach to protecting pharmaceuticals with specialized packaging that can build a unique identity for brands,” according to Dan L’Ecuyer, Vice President of Sales & Marketing at CSP Technologies.

L’Ecuyer continued, “Rather than use a desiccant chip inside a separate well in a blister, our proven technologies provides all the protection without increasing blister size and material or shipping costs.”

CSP’s patented technology integrates precise desiccant, gas-absorption, and sealing properties into the blister-pack itself, extending shelf life and product performance.

Activ-Blister® exhibits excellent performance capacity with moisture absorption up to 20mgs and oxygen scavenging up to 30ccs.

In addition, CSP’s Activ-Blister®® technology is available in a variety of sizes, including all type of round tablets and capsules up to size 0, with either multilayer barrier films or aluminum foil blisters to provide protection from both moisture and oxygen.

“Safely preserving drug potency and extending shelf life are high priorities for pharmaceutical manufacturers, and for the patients who rely on their products,” says L’Ecuyer.

“Activ-Blister®, CSP’s breakthrough solid dose packaging technology provides a strong product solution that meets customer needs while also safeguarding patient health.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Survey of New York City Soil Uncovers Medicine-Making Microbes
Microbes have long been an invaluable source of new drugs. And to find more, we may have to look no further than the ground beneath our feet.
Drug Design Strategy to Improve Breast Cancer Treatment
Scientists develop novel structure-based drug design strategy aimed at altering the basic landscape of hormone-driven breast cancer treatment.
`Molecular Commando’ Identified to Tackle Hypoxia Pathway
Scientists identify 'molecular commando' that can activate hypoxic response, which helps combat a number of conditions.
Peer Review is in Crisis, But Should be Fixed, Not Abolished
After the time to get the science done, peer review has become the slowest step in the process of sharing studies, and some scientists have had enough.
Two Antibiotics Fight Bacteria Differently Than Thought
Researchers discover that two widely prescribed antibiotics may fight bacteria differently than previously thought.
Drug Target for Gastrointestinal Stromal Tumors Identified
Researchers show the Hedgehog signaling pathway is central to the formation of gastrointestinal stromal tumors.
Structure of Primary Cannabinoid Receptor is Revealed
The findings provide key insights into how natural and synthetic cannabinoids including tetrahydrocannabinol —a primary chemical in marijuana—bind at the CB1 receptor to produce their effects.
Targeting Cannabinoid CB2 Receptors in the CNS
With endogenous cannabinoids considered as a potential target to combat CNS diseases, this article examines the role of CB2R could play in fighting some disorders.
3D-Printing in Science: Conference Co-Staged with LABVOLUTION
LABVOLUTION 2017 will have an added highlight of a simultaneous conference, "3D-Printing in Science".
Charles River Acquires Agilux
Enhances Charles River’s early-stage capabilities in bioanalytical services.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!